trending Market Intelligence /marketintelligence/en/news-insights/trending/gw2afsa8f5m7ejghxqz9ew2 content esgSubNav
In This List

Scythian Biosciences appoints chief medical officer

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021

Blog

Post-webinar Q&A: Global Credit Risk Trends 2021 and Beyond

Blog

University Essentials: From Crisis to Resilience – Navigating Sustainable Recovery


Scythian Biosciences appoints chief medical officer

Canadian pharmaceutical company Scythian Biosciences Corp. named Michael Barnes to be chief medical officer.

Barnes, a clinical neurologist, is an honorary professor of neurological rehabilitation at the University of Newcastle.